Skip to NavigationSkip to content

News

Teva has released its second quarter financials and they do not make for great reading if you’re an investor.
Janssen has suffered a knockback as the FDA refused to recommend sirukumab for the treatment of moderate to severely active forms of the disease.
New research has indicated that thousands of pounds could be saved in blood cancer treatment by tapping into the unexplored properties of...
Researchers from Edinburgh Napier University have discovered a crucial step in bringing forward a cure for the common cold.
The news broke last week that scientists in the US had carried out the first gene editing testing in the country but the full details were...
This latest piece of good news for AZ, in receiving a Priority Review for acalabrutinib, comes after the same drug received a breakthrough...
The FDA has given its approval for the commercialisation of Celgene and Agios Pharmaceutical’s Idhifa for the treatment of relapsed or refractory...
Numbers released by the Office for National Statistics (ONC) has revealed that drug misuse deaths were at a record high, with 3,744 deaths in 2016....
Due to the anticipated disruption surrounding the outcome of negotiations, the EMA has released a continuity plan outlining its intentions to...
Daiichi Sankyo has settled a case alleging that it did not fully disclose adverse side-effects of its drug, Benicar, with a $300 million pay-out for...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches